宫颈癌合并宫腔积液的放疗疗效分析

来源 :实用癌症杂志 | 被引量 : 0次 | 上传用户:dengwj
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
自1980年1月至1990年12月,对1899例宫颈癌患者行单纯放射治疗,其中合并宫腔积液者171例,宫腔积液的发生与患者年龄、子宫位置及腔内治疗方法有关(P值分别<0.01、<0.01和<0.05)而与肿瘤的分期、病变类型及病理类型无关;合并宫腔积液者放疗后5a生存率低于对照组(P<0.05),其中放疗结束后宫腔积液持续存在、宫体大小超过孕6周、血性积液及积液量多于50ml者的5a生存率明显低于无积液组(P值分别<0.01、<0.01、<0.05及<0.05),对有上述情况的患者,要高度警惕宫体受侵,必要时要增大A点放疗剂量或行子宫切除以改善预后 From January 1980 to December 1990, 1899 cases of cervical cancer patients underwent radiotherapy alone, including 171 cases of uterine effusion, the occurrence of uterine fluid and the patient’s age, location of the uterus and endovascular treatment methods (P <0.01, <0.01 and <0.05 respectively), but not with tumor stage, type and pathological type. The survival rate of patients with uterine effusion after radiotherapy was lower than that of the control group (P < 0.05), in which the uterine effusion persisted after the end of radiotherapy, the size of the uterine body exceeded 6 weeks pregnant, bloody fluid and fluid volume more than 50ml 5a survival rate was significantly lower than the non-fluid group (P values ​​< 0.01, <0.01, <0.05, and <0.05). Patients with the above-mentioned conditions should be highly vigilant about the invasion of the uterus, if necessary, to increase the radiation dose at point A or to improve the hysterectomy Prognosis
其他文献
分别采用CHOP-VP16方案对52例和ProMACE-CytaBOM方案对30例非霍奇金淋巴瘤(NHL)进行化疗,结果显示,CHOP-VP16方案组的完全缓解率为51.9%(27/52),总有效率为92.3%(48/52);ProMACE-CytaBOM方案组的完全缓解率为43.3%(13/30),总有效率为90.0%(27/30)。两组的完全缓解率及总有效率比较,无显著性差异
期刊
期刊
目的 比较利多卡因和利多卡因加曲安奈德局部注射治疗肩周炎的临床疗效.方法 肩周炎患者40例,采用随机数字表法分为利多卡因组(L组,n=20)与曲安奈德组(S组,n=20),两组患者分
期刊